Liptak Vincent Paul
SEC insider (Form 3/4/5 filer). CIK 0002143905. General Counsel at BlossomHill Therapeutics, Inc. (BLSM). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SAN DIEGO, CA.
Companies Liptak Vincent Paul has filed insider reports for
- BlossomHill Therapeutics, Inc. (BLSM): Officer, General Counsel
Liptak Vincent Paul
CIK: 0002143905
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BLSM
BlossomHill Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
PurchaseDirect2.2K shares at avg. $16.00$35K - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
ConversionIndirect22.7K shares- - Aug 7, 2026BLSM
BlossomHill Therapeutics, Inc.
PurchaseDirect2.5K shares at avg. $15.80$40K - Aug 6, 2026BLSM
BlossomHill Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
46.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Purchase | 2,200 | $16.00 | $35,200 | Direct |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion | 22,687 | - | $0 | Indirect |
| Aug 7, 2026 | BLSM BlossomHill Therapeutics, Inc. | Purchase | 2,500 | $15.80 | $39,500 | Direct |
| Aug 6, 2026 | BLSM BlossomHill Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 46,561 | - | - | Direct |
1-4 of 4 transactions